Cargando…
Editorial: The inflammation markers in schizophrenia and bipolar disorder: Do we have promising results?
Autores principales: | Arslan, Ayla, Aydin, Orkun, Çökmüş, Fikret P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850097/ https://www.ncbi.nlm.nih.gov/pubmed/36684017 http://dx.doi.org/10.3389/fpsyt.2022.1128355 |
Ejemplares similares
-
Editorial: Have We Got Better in Making Our Schizophrenia Patients Better?
por: Jääskeläinen, Erika, et al.
Publicado: (2020) -
Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression
por: Tang, Yiguo, et al.
Publicado: (2021) -
Editorial: Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?
por: Misiak, Błazej, et al.
Publicado: (2019) -
Treatment-resistant schizophrenia: How far have we traveled?
por: Pandey, Ambu, et al.
Publicado: (2022) -
Editorial: The Role of Inflammation in the Etiology and Treatment of Schizophrenia
por: Köhler-Forsberg, Ole, et al.
Publicado: (2020)